5 Item 1A. Risk Factors 22 Item 1B. Unresolved Staff Comments 44 Item 1 C. Cybersecurity 44 Item 2. Properties 44 Item 3. Legal Proceedings 44 Item 4. Mine Safety Disclosures 44 PART II Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 45 Item 6. Reserved 45 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 46 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 55 It...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-25 | 2025-12-31 | 0001193125-26-124396 | EDGAR | 59K words |
| 2025-03-25 | 2024-12-31 | 0000950170-25-044099 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0000950170-24-039306 | EDGAR | — |
| 2023-03-22 | 2022-12-31 | 0001437749-23-007531 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001437749-22-004614 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001437749-21-007756 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001437749-20-006155 | EDGAR | — |
| 2019-03-28 | 2018-12-31 | 0001437749-19-005927 | EDGAR | — |
| 2018-03-08 | 2017-12-31 | 0001615774-18-001693 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001615774-17-001088 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-276160 | EDGAR | 35K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-106947 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069827 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124668 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095102 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058244 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001437749-23-031424 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001437749-23-023426 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001437749-23-014366 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0001437749-22-026178 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001437749-22-019359 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001437749-22-011508 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-25 | 0001193125-26-124393 | EDGAR | 3K words |
| 2026-02-20 | 0001193125-26-061412 | EDGAR | — |
| 2026-02-17 | 0001193125-26-054797 | EDGAR | — |
| 2026-02-11 | 0001193125-26-045628 | EDGAR | — |
| 2026-01-26 | 0001193125-26-021727 | EDGAR | — |
| 2026-01-09 | 0001193125-26-008314 | EDGAR | — |
| 2026-01-06 | 0001193125-26-003506 | EDGAR | — |
| 2025-12-04 | 0001193125-25-307516 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276140 | EDGAR | — |
| 2025-10-14 | 0001193125-25-238065 | EDGAR | — |
301 total filings indexed. 269 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001488039 |
| Ticker | ATOS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.atossatherapeutics.com |
| Listed | 2012-11-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report